advanced head and neck squamous cell carcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadlocally advanced head and neck squamous cell carcinoma

I am/have/hadsquamous cell carcinoma

I am/have/hadcarcinoma

I am/have/hadcancer

I am/have/hadkidney function tests

I am/have/haddefinitive treatment

I am/have/hadcaries

I am/have/hadmeasurable disease

I am/have/hadhead and neck cancer

I am/have/hadwhite blood cell count

I am/have/hadcancer of the head

I am/have/hadsquamous cell carcinoma of head and neck

I am/have/hadadvanced head and neck squamous cell carcinoma

added new label for I am/have/had

more

I am looking for

I am looking forapatinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma

This is a prospective, open-labelled study to evaluate the efficacy and safety of camrelizumab combined with apatinib mesylate in the induction treatment of patients with locally advanced head and neck squamous cell carcinoma who were judged surgically unresectable or appropriate for non-surgical definitive therapy. The objective response rate (ORR) and …

locally advanced head and neck squamous cell carcinoma

squamous cell carcinoma

cancer

carcinoma

kidney function tests

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.